Clinical Trial Update: Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of Ingavirin for influenza and acute respiratory infections in adolescents; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Respiratory Infection

Drugs mentioned

• Ingavirin

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Influenza, Human, Acute Respiratory Infection | Phase 3 | Status: COMPLETED